Loading contract…
BETAThis is a new independent transparency project, not an official government website. The data is sourced from public registers and may contain errors, so always verify against the official source. If you find a problem, please report it here.
Project title: NHS National Framework for Transition products commencing 1 February 2025
Offer reference number: CM/TNS/24/5713
Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) up to maximum of 24 months.
Potential periods of call-offs under the framework agreement:
CM/TNS/24/5713/01 - Eribulin Injection, Bosutinib Tablets and Liraglutide Injection
Lot 1 CESW: 01/02/2025 to 31/05/2026 (16 months)
Lot 2 LSNE: 01/02/2025 to 31/05/2026 (16 months)
Lot 3 NWLN: 01/02/2025 to 31/05/2026 (16 months)
Published By: Medicines Procurement and Supply Chain - NHS Medicines Value & Access, NHS England
| Supplier | Identifier | Award Value | Cross-References |
|---|---|---|---|
| Baxter Healthcare Ltd | 00461365 | ~£9,867,000 estimated from lot values | LOBBYIST WA Communications Ltd (3 quarters) |
| Biocon | - | ~£9,867,000 estimated from lot values | - |
| Dr.Reddy's Laboratories (UK) Limited | 01729064 | ~£9,867,000 estimated from lot values | - |
| Sun Pharma UK Ltd | 02992795 | ~£9,867,000 estimated from lot values | - |
| Thornton and Ross Ltd | 00185947 | ~£9,867,000 estimated from lot values | - |
| Zentiva Pharma UK Ltd | 02158996 | ~£9,867,000 estimated from lot values | - |
Government spending data: These suppliers have received £288,244,139 in 8,053 payments (over £25k) from The Christie NHS Foundation Trust, Department of Health and Social Care, NHS Supply Chain (DHSC-funded), Guy's and St Thomas' NHS FT, Manchester University NHS Foundation Trust and 11 more public bodies (2010-04-01 to 2026-03-31).